BRAF and colorectal carcinoma: Firstly, mutations in KRAS and BRAF are associated with distinct CRC development routes: KRAS, but not BRAF, mutations frequently occur as secondary events after mutations activating Wnt/β-catenin in the conventional CRC progression sequence9,10.